FGFR2 and neoplasm: Rettew et al. have previously reported that genetic upregulation of EphB2, FGFR2, and RET, which encode RTKs, increases the metastatic potential of tumor cells by enhancing cell proliferation, motility, invasion, and tumorigenicity [31, 32].